Literature DB >> 25614334

Inhibition of P2Y6 receptor-mediated phospholipase C activation and Ca(2+) signalling by prostaglandin E2 in J774 murine macrophages.

Masaaki Ito1, Isao Matsuoka2.   

Abstract

Extracellular nucleotides act as inflammatory mediators through activation of multiple purinoceptors. Under inflammatory conditions, the purinergic signalling is affected by various inflammatory mediators. We previously showed that prostaglandin (PG) E2 suppressed the elevation of intracellular Ca(2+) concentration ([Ca(2+)]i) stimulated by P2X4, P2Y2, and P2Y6 receptors in J774 murine macrophages. In this study, we examined the mechanism of PGE2 inhibitory effects on P2Y6 receptor-mediated function in J774 cells. The P2Y6 receptor agonist UDP induced a sustained elevation of [Ca(2+)]i by stimulating the phospholipase C (PLC) signalling pathway. PGE2 inhibited [Ca(2+)]i elevation and phosphatidylinositol (PI) hydrolysis in a concentration-dependent manner. J774 cells highly expressed the E-type prostanoid 2 (EP2) receptor subtype, a Gs-coupled receptor. PGE2 and a selective EP2 receptor agonist caused cyclic AMP (cAMP) accumulation in J774 cells. The inhibitory effects of PGE2 on P2Y6 receptor-mediated responses were mimicked by the selective EP2 receptor agonist. Although EP2 receptor is linked to adenylyl cyclase activation, PGE2-induced inhibition of Ca(2+) response and PI hydrolysis could not be mimicked by a lipophilic cAMP derivative, dibutyryl cAMP, or an adenylyl cyclase activator, forskolin. The inhibition of UDP-induced PLC activation by PGE2 was not affected by down-regulation of protein kinase C by phorbol-12-myristate-13-acetate treatment. PGE2 inhibited PLC activation induced by aluminium fluoride, but not by the Ca(2+)-ionophore, ionomycin. Finally, the inhibition of UDP-induced PLC activation by PGE2 was impaired by Gs knockdown using siRNA. These results suggest that EP2 receptor activation in macrophages negatively controls the Gq/11-PLC signalling through a Gs-mediated, but cAMP-independent signalling mechanism.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  EP2 receptor; Macrophage; P2Y(6) receptor; Phospholipase C; Prostaglandin E(2); UDP

Mesh:

Substances:

Year:  2015        PMID: 25614334     DOI: 10.1016/j.ejphar.2014.12.024

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Purinergic dysregulation causes hypertensive glaucoma-like optic neuropathy.

Authors:  Youichi Shinozaki; Kenji Kashiwagi; Kazuhiko Namekata; Akiko Takeda; Nobuhiko Ohno; Bernard Robaye; Takayuki Harada; Takeshi Iwata; Schuichi Koizumi
Journal:  JCI Insight       Date:  2017-10-05

2.  Prostaglandin E2 Impairs P2Y2/P2Y4 Receptor Signaling in Cerebellar Astrocytes via EP3 Receptors.

Authors:  Lucía Paniagua-Herranz; Juan C Gil-Redondo; Ma José Queipo; Silvia González-Ramos; Lisardo Boscá; Raquel Pérez-Sen; Ma Teresa Miras-Portugal; Esmerilda G Delicado
Journal:  Front Pharmacol       Date:  2017-12-22       Impact factor: 5.810

Review 3.  Microglia Purinoceptor P2Y6: An Emerging Therapeutic Target in CNS Diseases.

Authors:  Shehata Anwar; Vincent Pons; Serge Rivest
Journal:  Cells       Date:  2020-07-01       Impact factor: 6.600

4.  Synergistic Cytokine Production by ATP and PGE2 via P2X4 and EP3 Receptors in Mouse Bone-Marrow-Derived Mast Cells.

Authors:  Kosuke Obayashi; Kazuki Yoshida; Masa-Aki Ito; Tetsuya Mori; Kimiko Yamamoto; Toshiyashu Imai; Isao Matsuoka
Journal:  Cells       Date:  2022-02-10       Impact factor: 6.600

5.  Co-Stimulation of Purinergic P2X4 and Prostanoid EP3 Receptors Triggers Synergistic Degranulation in Murine Mast Cells.

Authors:  Kazuki Yoshida; Makoto Tajima; Tomoki Nagano; Kosuke Obayashi; Masaaki Ito; Kimiko Yamamoto; Isao Matsuoka
Journal:  Int J Mol Sci       Date:  2019-10-17       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.